T-cell receptor gene transfer for the treatment of leukemia and other tumors by Mirjam H.M. Heemskerk

Get full text

Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells. by Marleen M van Loenen, Renate S Hagedoorn, Renate de Boer, J H Frederik Falkenburg, Mirjam H M Heemskerk

Get full text

Reassessing human MHC-I genetic diversity in T cell studies by Roderick C. Slieker, Daniël O. Warmerdam, Maarten H. Vermeer, Remco van Doorn, Mirjam H. M. Heemskerk, Ferenc A. Scheeren

Get full text

Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis by Hetty Jolink, Renate S. Hagedoorn, Ellen L. Lagendijk, Jan W. Drijfhout, Jaap T. van Dissel, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition by Eytan Breman, Jurjen M. Ruben, Kees L. Franken, Mirjam H. M. Heemskerk, Dave L. Roelen, Frans H. Claas, Cees van Kooten

Get full text

Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy by Marieke Griffioen, Esther H.M. van Egmond, Michel G.D. Kester, Roel Willemze, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells by Marleen M. van Loenen, Renate de Boer, Ellis van Liempt, Pauline Meij, Inge Jedema, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies by Marleen M. van Loenen, Renate de Boer, Renate S. Hagedoorn, Esther H.M. van Egmond, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence by Els P. van Hees, Laura T. Morton, Dennis F. G. Remst, Anne K. Wouters, Astrid Van den Eynde, J. H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

Mass cytometric analysis unveils a disease-specific immune cell network in the bone marrow in acquired aplastic anemia by Emma S. Pool, Yvonne Kooy-Winkelaar, Vincent van Unen, Vincent van Unen, J.H. Frederik Falkenburg, Frits Koning, Mirjam H. M. Heemskerk, Jennifer M-L. Tjon

Get full text

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion by Miranda H Meeuwsen, Laura T Morton, Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst, Marleen M van Loenen, J H Frederik Falkenburg, Mirjam H M Heemskerk

Get full text

Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing by Jeltje F. de Vries, Peter A. von dem Borne, Simone A.P. van Luxemburg-Heijs, Mirjam H.M. Heemskerk, Roel Willemze, J.H. Frederik Falkenburg, Renèe M.Y. Barge

Get full text

Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity? by Jaap L. J. Hanssen, Johan Stienstra, Stefan A. Boers, Cilia R. Pothast, Hans L. Zaaijer, Jennifer M. Tjon, Mirjam H. M. Heemskerk, Mariet C. W. Feltkamp, Sandra M. Arend

Get full text

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential by Rosa A. van Amerongen, Laura T. Morton, Umesh G. Chaudhari, Dennis F.G. Remst, Renate S. Hagedoorn, Cathelijne W. van den Berg, Christian Freund, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure by Tassilo L. A. Wachsmann, Anne K. Wouters, Dennis F. G. Remst, Renate S. Hagedoorn, Miranda H. Meeuwsen, Eline van Diest, Jeanette Leusen, Jürgen Kuball, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk

Get full text

CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition by Tom A.W. Schoufour, Anneloes van der Plas - van Duijn, Ian Derksen, Marije Melgers, Jacqueline M.F. van Veenendaal, Claire Lensen, Mirjam H.M. Heemskerk, Jacques Neefjes, Ruud H.M. Wijdeven, Ferenc A. Scheeren

Get full text

Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application by Marieke Griffioen, H.M. Esther van Egmond, Helen Barnby-Porritt, Menno A.W.G. van der Hoorn, Renate S. Hagedoorn, Michel G.D. Kester, Nikolai Schwabe, Roel Willemze, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Get full text

Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells by Willemijn van der Wulp, Anna M. Gram, Boris Bleijlevens, Renate S. Hagedoorn, Can Araman, Robbert Q. Kim, Jan Wouter Drijfhout, Paul W. H. I. Parren, Richard G. Hibbert, Rob C. Hoeben, Sander I. van Kasteren, Janine Schuurman, Maaike E. Ressing, Mirjam H. M. Heemskerk

Get full text

Targeting epigenetic regulation and post-translational modification with 5-Aza-2’ deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy by Marieke Griffioen, Noel F C C de Miranda, Sumit Kumar, Jessie S Kroonen, Ilona J de Graaf, Alfred C O Vertegaal, Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst, Mirjam H M Heemskerk, Jessica P Roelands, Amina F A S Teunisse

Get full text

DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation by Sine R Hadrup, Marieke Griffioen, J H Frederik Falkenburg, Mirjam H M Heemskerk, Marian van de Meent, Michel G D Kester, Kyra J Fuchs, Marcus Göransson, Natasja W Ettienne, Rob C M de Jong, Eva A S Koster, Constantijn J M Halkes, Ferenc Scheeren, Peter van Balen

Get full text